arrow
L

Luca Simonelli

universita della svizzera italiana
H指数:20
被引数:3,276

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of a pan anti-SARS-CoV-2 monoclonal antibody with highly efficient infected cell killing capacity for novel immunotherapeutic approaches

发现具有高效感染细胞杀伤能力的泛anti-SARS-CoV-2单克隆抗体,用于新型免疫治疗方法

2024-12-090
PREAI
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses

墨西哥和巴西的人类抗体中和蜱传黄病毒

2024-06-010
OA
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages

单克隆IgG向二聚体和分泌型IgA的转化可恢复中和能力并防止Omicron谱系的感染

2024-01-0913
OAAI
Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technology

使用噬菌体展示技术通过结构指导的亲和力成熟使中和抗体适应病毒变体

2023-08-214
OA
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein

针对SARS-CoV-2刺突糖蛋白的冷线性表位和亚结构域1的人类中和抗体

2023-03-3139
OAAI
A conformational switch controlling the toxicity of the prion protein
2022-08-1022
OAAI
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study

医护人员对mRNA疫苗BNT162b2引起的SARS-CoV-2变异的体液和细胞介导反应: 一项纵向观察研究

2022-02-0125
OAAI
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

从大流行前健康供体中选择的SARS-CoV-2中和人重组抗体在RBD-ACE2界面上结合

2021-03-1163
OAAI
Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery (vol 18, pg 1173, 2016)
2017-01-016
OAAI
Translocon component Sec62 acts in endoplasmic reticulum turnover during stress recovery
2016-10-17351
OAAI
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
2015-07-27199
OAAI